Clinical trial

Quantitative 18F-AV-133 PET Imaging in Subjects With Diabetes and Healthy Controls

NCT01710371

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-12-01

PhasePHASE1

Study timeline

Study start (unknown)2012-12-01Date precision: month

Registry last updated2015-11-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 2 Diabetesunresolved

Interventions

18F-AV-133DRUG

10% Arginine Hydrochloride-R-Gene 10DRUG

Sponsors & collaborators

Avid Radiopharmaceuticalslead sponsor

Pfizercollaborator

Mapped research locations

New HavenConnecticut, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01710371 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.